跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ipralin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ipralin
Approved
STANDARD
Ipralin
Aristopharma Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2571f1cad87e1ced
Company
Aristopharma Ltd.
Type
Standard
Approval Details
Approval Id
2571f1cad87e1ced
Drug Approval Philippines Name
Ipralin
Product Name
Ipralin
Registration Number
DR-XY45781
Brand Name
Ipralin
Generic Name
Ipratropium Bromide + Salbutamol (as Sulfate)
Dosage Form
Suspension Metered Dose Inhaler
Dosage Strength
20mcg/100mcg per actuation
Manufacturer
Aristopharma Ltd.
Importer
Sahar International Trading Inc.
Distributor
Sahar International Trading Inc.
Issuance Date
30 January 2022
Expiry Date
14 February 2027
Pharmacologic Category
Bronchodilator
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2571f1cad87e1ced
Type
Standard
Back to Philippines FDA Approvals